Beta-Blockers May Not Benefit Heart Attack Survivors With Normal Heart Function
New meta-analysis questions routine beta-blocker use after heart attacks in patients with preserved ejection fraction.
433 articles in this topic
New meta-analysis questions routine beta-blocker use after heart attacks in patients with preserved ejection fraction.
30-year study of 27,748 women reveals elevated Lp(a) significantly increases cardiovascular disease risk, suggesting population screening may be warranted.
New research shows neighborhood income and social factors influence health outcomes in genetic heart disease patients.
SHR-1918 antibody dramatically reduced LDL cholesterol in patients with severe genetic hypercholesterolemia through novel pathway.
Study of 16,401 pediatric heart surgeries reveals hospitals may select easier cases after public reporting begins, masking true quality improvements.
Major study reveals dramatic improvements in cardiomyopathy survival rates from 2004-2023, offering hope for heart health.
New research challenges conventional wisdom about optimal blood pressure targets for diabetic patients and cardiovascular outcomes.
New research reveals how wearable technology can catch dangerous atrial fibrillation before symptoms appear in high-risk seniors.
5-year study reveals timing of coronary angiography doesn't affect survival in cardiac arrest patients without obvious heart attack signs.
New framework proposes treating interconnected organ diseases together rather than separately for better outcomes.
Major heart studies frequently fail to report crucial long-term follow-up data, potentially missing delayed benefits and risks.
30-year Harvard study reveals healthy versions of both low-carb and low-fat diets reduce heart disease risk by similar amounts.